Remedy for Neuropathic Pain Could Be in The Offing

Remedy for Neuropathic Pain Could Be in The Offing

  • Research Stash
  • News
  • 1.4K

A remedy may finally be in the offing for neuropathic pain, which is a form of chronic pain that arises due to neuronal injury because of accidents, amputation, surgeries, cancer, diabetes and other such ailments. Researchers at Bengaluru-based Indian Institute of Science have found that lysozyme, an antibacterial protein that is found in body secretions like tears and saliva could be a leading cause for this type of pain.

Dr. Avadhesha Surolia and Dr.Saurabh Yadav at their laboratory
Dr. Avadhesha Surolia and Dr.Saurabh Yadav at their laboratory

Pain is an essential component for the maintenance of the body’s equilibrium as it acts as an alarm against hazardous stimuli and thus helps in avoiding potentially damaging conditions. Neuropathic pain arises because of injury to the neurons themselves. It is difficult to manage it as non-steroid anti-inflammatory drugs, the classical painkillers, are not very effective against it. One needs to use Opioids. They are effective. However, they are addictive and hence, are not widely recommended.

In the new research, the scientists have found that any injury to the neuron led to an increase in the level of lysozyme protein in it and this, in turn, activated a protein called `Toll-like receptor-4‘on the neuronal cell surface leading to development of pain and that application of lysozyme inhibitors subsequently resulted in pain relief. The experiment was conducted on laboratory rat models for pain.

They also observed increased levels of lysozyme protein in spinal cord injury patient’s spinal cord tissues and found that application of lysozyme on human nerve cells results in increased neuronal activity, which is a common condition during neuropathic pain.

Speaking to India Science Wire, leader of the study team and SERB Distinguished Fellow and honorary Professor at the Molecular Biophysics Unit of the Institute, Prof. Avadhesha Surolia, said, “The study may help in advancing our understanding of neuropathic pain and many neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Multiple sclerosis also as lysozyme levels are increased in these too”.

He conducted the study with his colleague, Dr. Saurabh Yadav. The two have published a report on their work in Science Translational Medicine. (ISW)

Sunderarajan Padmanabhan

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

Rate

They also observed increased levels of lysozyme protein in spinal cord injury patient’s spinal cord tissues and found that application of lysozyme on human nerve cells results in increased neuronal activity, which is a common condition during neuropathic pain.

Speaking to India Science Wire, leader of the study team and SERB Distinguished Fellow and honorary Professor at the Molecular Biophysics Unit of the Institute, Prof. Avadhesha Surolia, said, “The study may help in advancing our understanding of neuropathic pain and many neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and Multiple sclerosis also as lysozyme levels are increased in these too”.

He conducted the study with his colleague, Dr. Saurabh Yadav. The two have published a report on their work in Science Translational Medicine. (ISW)

Sunderarajan Padmanabhan

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }
Study Warns Kala Azar Patients Can Infect Others Even After Treatment

Study Warns Kala Azar Patients Can Infect Others Even After Treatment

Adding a new dimension to the fight against kala-azar, a study has highlighted the need to keep track of patients even after they are treated successfully to see whether they develop a skin condition called post-kala-azar dermal leishmaniasis down the line

  • News
  • 1.9K
Read more
Drs. Neetu Kalra, Vishal Rai, Sanjeev Shukla, Maheshwer reddy Chilamari (Left to Right)

Scientists Develop New Method to Synthesize Bio-Conjugates

In a promising development in the area of targeted treatment of cancer, a team of researchers at the Indian Institute of Science Education and Research (IISER), Bhopal, have developed a new method to synthesize antibody-drug conjugates (ADC) using the chemical route.

  • News
  • 2.1K
Read more
Nurturing Young Talents of North-East for Science

Nurturing Young Talents of North-East for Science

Sci-Connect, the programme consisted of a series of quiz competitions at different levels that will culminate in the final round where top three teams of three students each would be selected and presented cash awards

  • News
  • 1.9K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit